These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 26163040)

  • 1. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.
    Lu C; Wu W; Liu F; Yang K; Li J; Liu Y; Wang R; Si N; Gao P; Liu Y; Zhang S; Zhang X
    J Transl Med; 2018 Aug; 16(1):241. PubMed ID: 30165862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compound mutations in the MYBPC3 gene.
    Schaefer E; Helms P; Marcellin L; Desprez P; Billaud P; Chanavat V; Rousson R; Millat G
    Eur J Med Genet; 2014 Mar; 57(4):129-32. PubMed ID: 24602869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
    Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
    Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
    Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations.
    Michels M; Soliman OI; Kofflard MJ; Hoedemaekers YM; Dooijes D; Majoor-Krakauer D; ten Cate FJ
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):58-64. PubMed ID: 19356534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy.
    Zhao Y; Feng Y; Zhang YM; Ding XX; Song YZ; Zhang AM; Liu L; Zhang H; Ding JH; Xia XS
    Int J Mol Med; 2015 Dec; 36(6):1479-86. PubMed ID: 26458567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.
    Ader F; De Groote P; Réant P; Rooryck-Thambo C; Dupin-Deguine D; Rambaud C; Khraiche D; Perret C; Pruny JF; Mathieu-Dramard M; Gérard M; Troadec Y; Gouya L; Jeunemaitre X; Van Maldergem L; Hagège A; Villard E; Charron P; Richard P
    Clin Genet; 2019 Oct; 96(4):317-329. PubMed ID: 31245841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Diversity of Cardiomyopathy Caused by an
    Park J; Lee JM; Cho JS
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
    Wang P; Zou Y; Fu C; Zhou X; Hui R
    Biochem Biophys Res Commun; 2005 Apr; 329(2):796-9. PubMed ID: 15737656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titin mutation in familial restrictive cardiomyopathy.
    Peled Y; Gramlich M; Yoskovitz G; Feinberg MS; Afek A; Polak-Charcon S; Pras E; Sela BA; Konen E; Weissbrod O; Geiger D; Gordon PM; Thierfelder L; Freimark D; Gerull B; Arad M
    Int J Cardiol; 2014 Jan; 171(1):24-30. PubMed ID: 24315344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel
    Tong W; Liu W; Guo H; Wang J; Yu S; Zhang J; Liu C; Chen J; Zhao X
    Cardiol Young; 2020 Jan; 30(1):100-106. PubMed ID: 31747981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
    Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
    Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel αB-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy.
    Brodehl A; Gaertner-Rommel A; Klauke B; Grewe SA; Schirmer I; Peterschröder A; Faber L; Vorgerd M; Gummert J; Anselmetti D; Schulz U; Paluszkiewicz L; Milting H
    Hum Mutat; 2017 Aug; 38(8):947-952. PubMed ID: 28493373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Wide and Specific Spectrum of Genetic Variants and Genotype-Phenotype Correlations Revealed by Next-Generation Sequencing in Patients with Left Ventricular Noncompaction.
    Wang C; Hata Y; Hirono K; Takasaki A; Ozawa SW; Nakaoka H; Saito K; Miyao N; Okabe M; Ibuki K; Nishida N; Origasa H; Yu X; Bowles NE; Ichida F;
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.